---
title: "Understanding the Market | TOUYUN BIOTECH soared over 70% in the afternoon, Shanxi TOUYUN BIOTECH signed a 1 billion yuan order for Rhizoclonium products"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/263669740.md"
description: "TOUYUN BIOTECH surged over 70% in the afternoon, and as of the time of writing, it rose 51.59% to HKD 0.191, with a trading volume of HKD 3.6999 million. According to news from Changzhi Daily, on October 24th, Shanxi TOUYUN BIOTECH Co., Ltd. signed a strategic cooperation agreement with a sales consortium formed by Shenzhen Building Supply Chain Technology Co., Ltd., Henan Guozihao Marketing Management Co., Ltd., and Beijing HeWanjia Biotechnology Co., Ltd. According to the agreement, from 2026 to the end of 2028, the consortium will purchase TOUYUN BIOTECH's Rhine Spirulina series products worth no less than 1 billion yuan. Public information shows that Shanxi TOUYUN BIOTECH is committed to developing advanced fermentation technology to produce the green food of the new century—Rhine Spirulina. The company is a wholly-owned subsidiary of the Hong Kong-listed TOUYUN BIOTECH Group. The signing of the 1 billion yuan strategic cooperation agreement by Shanxi TOUYUN BIOTECH marks the official entry of Rhine Spirulina into the harvest period of large-scale commercial monetization"
datetime: "2025-10-31T07:30:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/263669740.md)
  - [en](https://longbridge.com/en/news/263669740.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/263669740.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/263669740.md) | [English](https://longbridge.com/en/news/263669740.md)


# Understanding the Market | TOUYUN BIOTECH soared over 70% in the afternoon, Shanxi TOUYUN BIOTECH signed a 1 billion yuan order for Rhizoclonium products

According to Zhitong Finance APP, TOUYUN BIOTECH (01332) surged over 70% in the afternoon, and as of the time of writing, it rose 51.59% to HKD 0.191, with a transaction volume of HKD 3.6999 million.

In terms of news, according to Changzhi Daily, on October 24th, Shanxi TOUYUN BIOTECH Co., Ltd. signed a strategic cooperation agreement with a sales consortium composed of Shenzhen Building Supply Chain Technology Co., Ltd., Henan Guozihao Marketing Management Co., Ltd., and Beijing HeWanjia Biotechnology Co., Ltd. According to the agreement, from 2026 to the end of 2028, the consortium will purchase TOUYUN BIOTECH's series of products worth no less than 1 billion yuan.

Public information shows that Shanxi TOUYUN BIOTECH is committed to developing advanced fermentation technology to produce the green food of the new century—Rhein Spirulina. The company is a wholly-owned subsidiary of the Hong Kong-listed TOUYUN BIOTECH Group. The signing of the 1 billion yuan strategic cooperation agreement by Shanxi TOUYUN BIOTECH marks the official entry of Rhein Spirulina into the harvest period of large-scale commercial monetization

### 相關股票

- [TOUYUN BIOTECH (01332.HK)](https://longbridge.com/zh-HK/quote/01332.HK.md)

## 相關資訊與研究

- [CATL's controlling shareholder to donate some A-shares](https://longbridge.com/zh-HK/news/281197776.md)
- [Results: Flat Glass Group Co., Ltd. Beat Earnings Expectations And Analysts Now Have New Forecasts](https://longbridge.com/zh-HK/news/280891760.md)
- [C-MER Medical Declares HKD 0.02 Final Dividend for FY2025](https://longbridge.com/zh-HK/news/280775289.md)
- [Precise Biometrics Calls EGM to Approve Merger With Fingerprint Cards](https://longbridge.com/zh-HK/news/281003945.md)
- [08:41 ETGELITA Champions "BE ACTIVE!" at SupplySide Connect with Innovative Collagen Solutions and Delivery Formats](https://longbridge.com/zh-HK/news/281189481.md)